Hyperoxaluria: a gut-kidney axis? (Q27013855)

Bernd Hoppe

series ordinal

2

1 reference

Benjamin A. Vervaet

series ordinal

3

1 reference

Anja Verhulst

series ordinal

5

1 reference

language of work or name

1 reference

December 2011

1 reference

1 reference

80

1 reference

PubMed

issue

11

1 reference

PubMed

page(s)

1146-58

1 reference

Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Hyperoxaluric calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

An active renal crystal clearance mechanism in rat and man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Renal function in patients with nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Kidney stones and the risk for chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The primary hyperoxalurias

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Nephrocalcinosis: new insights into mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Dependence of upper limit of metastability on supersaturation in nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Calcium oxalate nephrolithiasis, a free or fixed particle disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding- into a nonadherent epithelium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Proposed mechanisms in renal tubular crystal retention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The tubular epithelium in the initiation and course of intratubular nephrocalcinosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Physiopathology and etiology of stone formation in the kidney and the urinary tract

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Mechanism of calcium oxalate renal stone formation and renal tubular cell injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Probiotics and dietary manipulations in calcium oxalate nephrolithiasis: two sides of the same coin?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Contribution of dietary oxalate to urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The impact of dietary oxalate on kidney stone formation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Dietary oxalate loads and renal oxalate handling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate synthesis from [14C1]glycollate and [14C1]glyoxylate in the hepatectomized rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Glyoxylate synthesis, and its modulation and influence on oxalate synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

4-Hydroxyproline metabolism and glyoxylate production: A target for substrate depletion in primary hyperoxaluria?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Hydroxyproline ingestion and urinary oxalate and glycolate excretion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Control of oxalate formation from L-hydroxyproline in liver mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate in renal stone disease: the terminal metabolite that just won't go away.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Fructose consumption and the risk of kidney stones

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Increase in urinary calcium and oxalate after fructose infusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Urinary calcium and oxalate excretion during oral fructose or glucose load in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Metabolism of fructose to oxalate and glycolate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Ascorbate increases human oxaluria and kidney stone risk

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Effect of megadoses of ascorbic acid on serum and urinary oxalate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Sensitive spectrophotometric assay for plasma oxalate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The primary hyperoxalurias

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Mutations in DHDPSL are responsible for primary hyperoxaluria type III

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Estimation of the oxalate content of foods and daily oxalate intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Dietary risk factors for hyperoxaluria in calcium oxalate stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Nutritional value of foods in relation to their oxalic acid content

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Dependence of oxalate absorption on the daily calcium intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Effect of dietary calcium on urinary oxalate excretion after oxalate loads

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

[13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Mass spectrometric-selected ion monitoring assay for an oxalate absorption test applying [13C2]oxalate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Influence of a high-oxalate diet on intestinal oxalate absorption

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The urinary response to an oral oxalate load in recurrent calcium stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate synthesis, transport and the hyperoxaluric syndromes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Determinants of 24-hour urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Intestinal and renal handling of oxalate loads in normal individuals and stone formers.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Stones from bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Hyperoxaluria in kidney stone formers treated with modern bariatric surgery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Nephrolithiasis after bariatric surgery for obesity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Plasma Level and Renal Clearance of Oxalate in Normal Subjects and in Patients with Primary Hyperoxaluria or Chronic Renal Failure or Both

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Effect of renal transplantation on serum oxalate and urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The solute carrier 26 family of proteins in epithelial ion transport

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The SLC26 gene family of multifunctional anion exchangers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Renal physiology of SLC26 anion exchangers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

SLC26 chloride/base exchangers in the kidney in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The liver and kidney expression of sulfate anion transporter sat-1 in rats exhibits male-dominant gender differences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Ability of sat-1 to transport sulfate, bicarbonate, or oxalate under physiological conditions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Regulation of the expression of the hepatocellular sulfate-oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: a metabolic link between liver and kidney?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Intestinal transport of an obdurate anion: oxalate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Characterization of the Human Sulfate Anion Transporter (hsat-1) Protein and Gene (SAT1; SLC26A1)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Glyoxylate is a substrate of the sulfate-oxalate exchanger, sat-1, and increases its expression in HepG2 cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Regulated transport of sulfate and oxalate by SLC26A2/DTDST.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Specificity of anion exchange mediated by mouse Slc26a6

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Molecular characterization of the murine Slc26a6 anion exchanger: functional comparison with Slc26a1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Parsing apical oxalate exchange in Caco-2BBe1 monolayers: siRNA knockdown of SLC26A6 reveals the role and properties of PAT-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

SLC26A7: a basolateral Cl-/HCO3- exchanger specific to intercalated cells of the outer medullary collecting duct

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Immunolocalization of anion transporter Slc26a7 in mouse kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

SLC26A7 is a Cl- channel regulated by intracellular pH

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

SLC26A6 and SLC26A7 anion exchangers have a distinct distribution in human kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Identification of a basolateral Cl-/HCO3- exchanger specific to gastric parietal cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The SLC4 family of HCO 3 - transporters

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Characterization of oxalate transport by the human erythrocyte band 3 protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controls.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Renal Elimination Kinetics and Plasma Half-Life of Oxalate in Man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Transport of oxalate across the rabbit papillary surface epithelium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Mechanism of formation of human calcium oxalate renal stones on Randall's plaque

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Protein localization of SLC26A2 (DTDST) in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Gating of CFTR by the STAS domain of SLC26 transporters

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Factors increasing the risk for stone formation in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

The stomach: a new and powerful oxalate absorption site in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Characteristics of the transport of oxalate and other ions across rabbit proximal colon

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Mechanisms of oxalate absorption and secretion across the rabbit distal colon

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Renal and intestinal transport defects in Slc26a6-null mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Management of primary hyperoxaluria: efficacy of oral citrate administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Renal handling of citrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Clinical implications of mutation analysis in primary hyperoxaluria type 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Use of a probiotic to decrease enteric hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

14-day repeat-dose oral toxicity evaluation of oxazyme in rats and dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Use of sevelamer hydrochloride as an oxalate binder

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Nicotinamide suppresses hyperphosphatemia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Characteristics of rat downregulated in adenoma (rDRA) expressed in HEK 293 cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Colocalization of the apical Cl-/HCO3- exchanger PAT1 and gastric H-K-ATPase in stomach parietal cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Identification of an apical Cl-/HCO-3 exchanger in rat kidney proximal tubule

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl- oxalate transporter in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.287

7 January 2021

Identifiers

DOI

10.1038/KI.2011.287

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

3118465

1011905982

0 references

Fatcat ID

release_4dsr5vanm5hkxnrli54osqnrva

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4dsr5vanm5hkxnrli54osqnrva

24 November 2022

mapped directly with Wikidata item

3118465

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference